1. Home
  2. SHCO vs AUPH Comparison

SHCO vs AUPH Comparison

Compare SHCO & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHCO
  • AUPH
  • Stock Information
  • Founded
  • SHCO 1995
  • AUPH 1993
  • Country
  • SHCO United States
  • AUPH Canada
  • Employees
  • SHCO N/A
  • AUPH N/A
  • Industry
  • SHCO Hotels/Resorts
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHCO Consumer Discretionary
  • AUPH Health Care
  • Exchange
  • SHCO Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • SHCO 1.0B
  • AUPH 1.0B
  • IPO Year
  • SHCO 2021
  • AUPH 1999
  • Fundamental
  • Price
  • SHCO $5.40
  • AUPH $7.32
  • Analyst Decision
  • SHCO Strong Buy
  • AUPH Strong Buy
  • Analyst Count
  • SHCO 3
  • AUPH 3
  • Target Price
  • SHCO $7.00
  • AUPH $10.33
  • AVG Volume (30 Days)
  • SHCO 84.9K
  • AUPH 796.1K
  • Earning Date
  • SHCO 11-12-2024
  • AUPH 11-07-2024
  • Dividend Yield
  • SHCO N/A
  • AUPH N/A
  • EPS Growth
  • SHCO N/A
  • AUPH N/A
  • EPS
  • SHCO N/A
  • AUPH N/A
  • Revenue
  • SHCO $1,160,039,000.00
  • AUPH $207,105,000.00
  • Revenue This Year
  • SHCO $10.13
  • AUPH $36.05
  • Revenue Next Year
  • SHCO $8.23
  • AUPH $18.87
  • P/E Ratio
  • SHCO N/A
  • AUPH N/A
  • Revenue Growth
  • SHCO 7.35
  • AUPH 29.35
  • 52 Week Low
  • SHCO $4.35
  • AUPH $4.71
  • 52 Week High
  • SHCO $8.49
  • AUPH $10.05
  • Technical
  • Relative Strength Index (RSI)
  • SHCO 50.02
  • AUPH 57.03
  • Support Level
  • SHCO $5.17
  • AUPH $6.85
  • Resistance Level
  • SHCO $5.49
  • AUPH $7.50
  • Average True Range (ATR)
  • SHCO 0.21
  • AUPH 0.20
  • MACD
  • SHCO 0.01
  • AUPH 0.01
  • Stochastic Oscillator
  • SHCO 51.44
  • AUPH 72.31

About SHCO Soho House & Co Inc.

Soho House & Co Inc is a membership platform of physical and digital spaces that connects a vibrant, diverse group of members from across the world. The members use the platform to work, socialize, connect, create and flourish all over the world. It offers lease agreement Houses, hotels, restaurants, studios, spas, and other properties. The company's reportable segments are; United Kingdom, North America, and Europe and Rest of the World. Majority of its revenue is generated from the North America segment which encompasses its operating units in North America, including; Soho Houses, stand-alone U.S. restaurants and the Willows Inn in Palm Springs, Soho Friends, and the management fees from Soho Beach House Canouan.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: